株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

3Dバイオプリンティングの世界市場予測(2019年~2025年)

Global 3D Bioprinting Market 2019-2025

発行 Orion Market Research Pvt Ltd 商品コード 920447
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.49円で換算しております。
3Dバイオプリンティングの世界市場予測(2019年~2025年) Global 3D Bioprinting Market 2019-2025
出版日: 2019年12月20日 ページ情報: 英文
概要

世界の3Dバイオプリンティング市場は、予測期間中に大幅に成長すると予想されています。市場成長に寄与している主な要因には、生活習慣病の発生率の上昇、臓器および組織移植の大規模な需要などがあります。たとえば、米国の保健資事業局(HRSA)によると、2018年には36,528件の臓器移植が行われました。2018年1月現在、113,000人以上が臓器移植を待っています。限られた数の臓器提供者も、3Dバイオプリンティング市場の成長に貢献しています。米国保健福祉省によると、10分ごとに全国移植待機者リストに名前が追加されています。移植待機リストの増加により、3Dバイオプリントのインプラントおよび臓器の可能性が生じています。

当レポートでは、世界の3Dバイオプリンティング市場について調査分析し、市場概要、市場決定要因、市場区分、競合情勢、地域別分析、主要企業などについて、体系的な情報を提供しています。

目次

第1章 レポート概要

  • 調査方法とツール
  • 市場分析
    • セグメント別
    • 地域別

第2章 市場概要と考察

  • レポートの範囲
  • アナリストの考察と最新市場動向
    • 主な調査結果
    • 提言
    • 結論
  • 規則・規制

第3章 競争環境

  • 企業シェア分析
  • 主要戦略分析
  • 主要企業分析
    • 3D Systems Corp.
    • Organovo Holdings、Inc.
    • CELLINK AB
    • CollPlant Ltd.
    • Stratasys Ltd.

第4章 市場の決定要因

  • 成長要因
  • 阻害要因
  • 市場機会

第5章 市場セグメンテーション

  • 技術別市場
    • 押出ベース
    • レーザーベース
    • インクジェットベース
    • その他(マイクロバルブベースおよびステレオリソグラフベース)
  • アプリケーション別市場
    • 薬物検査と開発
    • 3D細胞培養
    • 組織および臓器の再生
    • その他(食品試験)

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 会社概要

  • 3D Bioprinting Solutions
  • 3D Systems Corp.
  • Advanced BioMatrix, Inc.
  • Aleph Objects, Inc.
  • Allevi
  • Aspect Biosystems Ltd.
  • CELLINK AB
  • CollPlant Ltd.
  • Cyfuse Biomedical KK
  • Digilab, Inc.
  • EnvisionTEC, Inc.
  • Formlabs Inc.
  • GeSiM GmbH
  • Materialise NV
  • Medprin Biotech GmbH
  • Nano3D Biosciences, Inc.
  • Organovo Holdings Inc.
  • Poietis
  • REGEMAT 3D S.L.
  • regenHU Ltd.
  • Regenovo Biotechnology Co., Ltd.
  • Stratasys, Ltd.
  • United Therapeutics Corp.
図表

List of Tables

  • 1. GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 2. GLOBAL EXTRUSION-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL LASER-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL INKJET-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL OTHER 3D BIOPRINTING TECHNOLOGIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 7. GLOBAL 3D BIOPRINTING FOR DRUG TESTING AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL 3D BIOPRINTING FOR 3D CELL CULTURE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL 3D BIOPRINTING FOR TISSUE AND ORGAN REGENERATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL 3D BIOPRINTING FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 13. NORTH AMERICAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 14. NORTH AMERICAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 15. EUROPEAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 16. EUROPEAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 17. EUROPEAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 18. ASIA-PACIFIC 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 19. ASIA-PACIFIC 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 20. ASIA-PACIFIC 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 21. REST OF THE WORLD 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 22. REST OF THE WORLD 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL 3D BIOPRINTING MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
  • 2. GLOBAL 3D BIOPRINTING MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 3. GLOBAL 3D BIOPRINTING MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2020057

3D Bioprinting Market Size, Share & Trends Analysis Report, By Technology (Extrusion-Based, Laser-Based, Inkjet-Based and Others), By Application (Drug Testing and Development, 3D Cell Culture, Tissue and Organ Regeneration, and Others) and Forecast 2019-2025

The global 3D bioprinting market is anticipated to grow at a significant rate during the forecast period. The major factors contributing to the growth of the market include rising incidences of lifestyle-oriented diseases and massive demand for organ & tissue transplants. For instance, as per the Health Resources and Services Administration (HRSA), in the US, 36,528 organ transplants were performed in 2018. As of January 2018, more than 113,000 people are waiting for organ transplantation. A limited number of organ donors has also contributed towards the growth of the 3D bioprinting market. According to the US Department of Health & Human Services, in every 10 minutes, an individual is added to the national transplant waiting list. The growth in the waiting list of transplants has created a potential for the 3D bio-printed implants and organs.

The global 3D bioprinting market is segmented on the basis of technology and application. On the basis of technology, the market is segmented into extrusion-based, laser-based, inkjet-based and others. Extrusion-based technology is expected to hold a significant share in the global 3D bioprinting market. Further, on the basis of application, the market is segmented into drug testing and development, 3D cell culture, tissue and organ regeneration, and others. Drug testing and development is expected to contribute significantly to the growth of the market.

The global 3D bioprinting market geographically covers the analysis of four major regions; North America (the US and Canada), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and RoW. North America dominated the global 3D bioprinting market in 2018. A rise in the demand for organ transplantation along with reasonably higher patient disposable income and sophisticated healthcare infrastructure are some of the key drivers for the regional growth of the market.

Moreover, the market is fragmented in nature with the presence of several players. Some of the key players operating in the market include Organovo Holdings, Inc., 3D Systems Corp., CELLINK AB, Stratasys Ltd., and CollPlant Ltd. The market players are teaming up with universities and research institutes that work on grafting as well as organ regeneration technologies. In 2015, Organovo Holding Inc. participated in Cantor Fitzgerald Inaugural Healthcare Conference with an aim to increase awareness related to their current activities in 3D bioprinting market.

Research Methodology

The market study of the global 3D bioprinting market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for 3D bioprinting manufacturers, suppliers, and distributors, cosmetic product manufacturers, suppliers, and distributors, pharmaceutical and biotechnology companies, healthcare organizations, medical research laboratories, academic and research institutes, and government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better market decisions.

Market Segmentation:

1. Global 3D Bioprinting Market Research and Analysis, By Technology

2. Global 3D Bioprinting Market Research and Analysis, By Application

The Report covers:

  • Comprehensive research methodology of the global 3D bioprinting market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global 3D bioprinting market.
  • Insights about market determinants which are stimulating the global 3D bioprinting market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. 3D Systems Corp.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Organovo Holdings, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. CELLINK AB
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. CollPlant Ltd.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Stratasys Ltd.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global 3D Bioprinting Market by Technology
    • 5.1.1. Extrusion-based
    • 5.1.2. Laser-based
    • 5.1.3. Inkjet-based
    • 5.1.4. Others (Microvalve-based and Stereolithography-based)
  • 5.2. Global 3D Bioprinting Market by Application
    • 5.2.1. Drug Testing and Development
    • 5.2.2. 3D Cell Culture
    • 5.2.3. Tissue and Organ Regeneration
    • 5.2.4. Others (Food Testing)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. 3D Bioprinting Solutions
  • 7.2. 3D Systems Corp.
  • 7.3. Advanced BioMatrix, Inc.
  • 7.4. Aleph Objects, Inc.
  • 7.5. Allevi
  • 7.6. Aspect Biosystems Ltd.
  • 7.7. CELLINK AB
  • 7.8. CollPlant Ltd.
  • 7.9. Cyfuse Biomedical KK
  • 7.10. Digilab, Inc.
  • 7.11. EnvisionTEC, Inc.
  • 7.12. Formlabs Inc.
  • 7.13. GeSiM GmbH
  • 7.14. Materialise NV
  • 7.15. Medprin Biotech GmbH
  • 7.16. Nano3D Biosciences, Inc.
  • 7.17. Organovo Holdings Inc.
  • 7.18. Poietis
  • 7.19. REGEMAT 3D S.L.
  • 7.20. regenHU Ltd.
  • 7.21. Regenovo Biotechnology Co., Ltd.
  • 7.22. Stratasys, Ltd.
  • 7.23. United Therapeutics Corp.